by Telethon Kids Institute Credit: Pixabay World-first immunizations providing protection against deadly respiratory syncytial virus (RSV) could be just months away thanks to global research efforts spanning multiple decades. The latest research published in The Lancet Infectious Diseases has revealed a long-lasting monoclonal antibody treatment for babies is likely to be accessible on the market within 12...
